These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10828454)

  • 1. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle.
    Zhu X; Hadhazy M; Wehling M; Tidball JG; McNally EM
    FEBS Lett; 2000 May; 474(1):71-5. PubMed ID: 10828454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle.
    Nishi M; Yasue A; Nishimatu S; Nohno T; Yamaoka T; Itakura M; Moriyama K; Ohuchi H; Noji S
    Biochem Biophys Res Commun; 2002 Apr; 293(1):247-51. PubMed ID: 12054591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
    Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of myostatin pro domain results in muscular transgenic mice.
    Yang J; Ratovitski T; Brady JP; Solomon MB; Wells KD; Wall RJ
    Mol Reprod Dev; 2001 Nov; 60(3):351-61. PubMed ID: 11599046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the compact mutant myostatin allele Mstn (Cmpt-dl1Abc) introgressed into a high growth mouse line on skeletal muscle cellularity.
    Rehfeldt C; Ott G; Gerrard DE; Varga L; Schlote W; Williams JL; Renne U; Bünger L
    J Muscle Res Cell Motil; 2005; 26(2-3):103-12. PubMed ID: 16003464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: a cluster analysis.
    Kim JS; Petrella JK; Cross JM; Bamman MM
    J Appl Physiol (1985); 2007 Nov; 103(5):1488-95. PubMed ID: 17673556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
    Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
    PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors.
    Allen DL; Unterman TG
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C188-99. PubMed ID: 16885393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality.
    Li ZF; Shelton GD; Engvall E
    Am J Pathol; 2005 Feb; 166(2):491-7. PubMed ID: 15681832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked reduction of focal adhesion kinase, serum response factor and myocyte enhancer factor 2C, but increase in RhoA and myostatin in the hindlimb dy mouse muscles.
    Sakuma K; Nakao R; Inashima S; Hirata M; Kubo T; Yasuhara M
    Acta Neuropathol; 2004 Sep; 108(3):241-9. PubMed ID: 15221330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Altered expression of myostatin gene in the progressive muscular dystrophy patients].
    Zhang Y; Chen Y; Chen JW; Zhu DH
    Yi Chuan Xue Bao; 2005 Aug; 32(8):779-83. PubMed ID: 16231730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
    Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
    FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic strategies for muscular dystrophy by myostatin inhibition].
    Sunada Y
    Rinsho Shinkeigaku; 2006 Nov; 46(11):942-4. PubMed ID: 17432227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myostatin gene silenced by RNAi show a zebrafish giant phenotype.
    Acosta J; Carpio Y; Borroto I; González O; Estrada MP
    J Biotechnol; 2005 Oct; 119(4):324-31. PubMed ID: 16005092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
    Tsuchida K
    Acta Myol; 2008 Jul; 27(1):14-8. PubMed ID: 19108572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.
    Sharma M; Kambadur R; Matthews KG; Somers WG; Devlin GP; Conaglen JV; Fowke PJ; Bass JJ
    J Cell Physiol; 1999 Jul; 180(1):1-9. PubMed ID: 10362012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoral morphology and cross-sectional geometry of adult myostatin-deficient mice.
    Hamrick MW; McPherron AC; Lovejoy CO; Hudson J
    Bone; 2000 Sep; 27(3):343-9. PubMed ID: 10962344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice.
    Wagner KR; McPherron AC; Winik N; Lee SJ
    Ann Neurol; 2002 Dec; 52(6):832-6. PubMed ID: 12447939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.